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The two major lineages of classical dendritic cells
(cDCs) express and require either IRF8 or IRF4
transcription factors for their development and func-
tion. IRF8-dependent cDCs promote anti-viral and
T-helper 1 (Th1) cell responses, whereas IRF4-ex-
pressing cDCs have been implicated in controlling
both Th2 and Th17 cell responses. Here, we have pro-
vided evidence that Kruppel-like factor 4 (Klf4) is
required in IRF4-expressing cDCs to promote Th2,
but not Th17, cell responses in vivo. Conditional Klf4
deletion within cDCs impaired Th2 cell responses
during Schistosoma mansoni infection, Schistosoma
egg antigen (SEA) immunization, and house dust
mite (HDM) challenge without affecting cytotoxic
T lymphocyte (CTL), Th1 cell, or Th17 cell responses
to herpes simplex virus, Toxoplasma gondii, and Cit-
robacter rodentium infections. Further, Klf4 deletion
reduced IRF4 expression in pre-cDCs and resulted
in selective loss of IRF4-expressing cDCs subsets in
several tissues. These results indicate thatKlf4guides
a transcriptional programpromoting IRF4-expressing
cDCs heterogeneity.
INTRODUCTION
Conventional dendritic cells (cDCs) are professional antigen-
presenting cells that play a key role in shaping appropriate
immune responses (Banchereau and Steinman, 1998; Merad
et al., 2013; Satpathy et al., 2012b; Mildner and Jung, 2014).
Several transcription factors have been implicated in cDCs
development, but the basis for specification and commitment
of cDC subsets is still incompletely understood (Belz and Nutt,
2012; Murphy, 2013). One major subset of cDCs identified by
the expression of CD8a in spleen, and CD24 or CD103 in the pe-
riphery, requires the transcription factors IRF8 (Hambleton et al.,
2011; Tailor et al., 2008), BATF3 (Edelson et al., 2010; Hildner
et al., 2008; Ginhoux et al., 2009), NFIL3 (Kashiwada et al.,
2011), and ID2 (Hacker et al., 2003; Spits et al., 2000). Selective
loss of CD8a+ and CD103+ cDCs in Batf3/mice demonstrated916 Immunity 42, 916–928, May 19, 2015 ª2015 Elsevier Inc.the specialization of this cDC subset in promoting anti-viral
immunity, tumor rejection, and protection against Toxoplasma
gondii infection (Mashayekhi et al., 2011; Hildner et al., 2008;
Tussiwand et al., 2012; Pinto et al., 2011; Torti et al., 2011).
The second major branch of cDCs is characterized by the
expression of IRF4 and CD11b and is developmentally impacted
by the transcription factors RelB, Traf6, Notch2, Irf2, and Irf4
(Mildner and Jung, 2014).
The function of CD11b+ cDCs in controlling different classes of
immune responses has been recently examined (Lewis et al.,
2011; Satpathy et al., 2013; Persson et al., 2013; Schlitzer
et al., 2013; Williams et al., 2013; Gao et al., 2013; Kumamoto
et al., 2013; Zhou et al., 2014). Conditional Notch2 deletion in
cDCs impaired development of CD11b+ cDCs expressing CD4
and the endothelial cell-selective adhesion molecule (ESAM)
(Lewis et al., 2011; Satpathy et al., 2013). Thesemice are suscep-
tible to infection with Citrobacter rodentium, resulting from a
requirement for interleukin-23 (IL-23) production by Notch2-
dependent cDCs early during infection (Satpathy et al., 2013).
Similarly, conditional deletion of Irf4 in cDCs causes a reduction
in the numbers of CD11b+ cDCs, and reduced IL-23 production
leading to impaired Th17 cell development in both lung and intes-
tine (Perssonet al., 2013;Schlitzer et al., 2013).Consistently,mice
lacking IRF4 expression in cDCs are therefore susceptible to pul-
monary infectionwithAspergillus fumigatus (Schlitzer et al., 2013).
Subsequent studies showed that Irf4-dependent CD11b+ cDCs
are involved in Th2 cell responses in skin and lung (Gao et al.,
2013; Kumamoto et al., 2013; Williams et al., 2013; Zhou et al.,
2014). However, other reports have demonstrated that IRF4
acts in both migration of CD11b+ cDCs (Bajan˜a et al., 2012) and
expression of major histocompatibility complex (MHC)-II and
co-stimulatory molecules in cDCs (Vander Lugt et al., 2014). As
a result, it is unclear whether there is a specific cDC subset
dedicated to Th2 cell priming that is selectively dependent on
IRF4, or whether IRF4 acts in all CD11b+ cDCs, affecting their
migration and maturation in both Th17 and Th2 cell responses.
We identified Kruppel-like factor 4 (Klf4) as a potential candi-
date for regulating the development of the IRF4-expressing
CD11b+ cDCs. Klf4 can act as a repressor or activator of tran-
scription and regulates development in several epithelial tissues,
including skin, lung, and intestine (Segre et al., 1999; Dang et al.,
2000; Katz et al., 2002; Dang et al., 2000; Ghaleb et al., 2005;
Feinberg et al., 2007; Alder et al., 2008; Zheng et al., 2009;
McConnell and Yang, 2010; Yamanaka, 2008; Yoshida and
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Figure 1. KLF-4 Deletion Impairs Development of Bone-Marrow pre-
cDC Progenitors
(A) Relative expression of Klf4, Irf8, and Irf4 determined by microarray analysis
is shown for the indicated stages of DC progenitors.Hayashi, 2014). In hematopoietic cells, Klf4 is expressed on
myeloid cells, is required for monocyte development (Feinberg
et al., 2007; Alder et al., 2008; Kurotaki et al., 2013), as well as
for in vitro M2 macrophage polarization (Feinberg et al., 2007;
Kurotaki et al., 2013; Terry and Miller, 2014). Klf4 conditional
deficient mice have reduced CD11b+ cDCs in spleen; however,
the nature of the defect was not further analyzed with respect
to cDC subsets or function (Park et al., 2012). Here we showed
that Klf4 is required within IRF4-expressing cDC subsets for
normal priming of Th2 cell responses. Our results indicated
that the IRF4-expressing cDC lineage is functionally heteroge-
neous, withKlf4 promoting aDC transcriptional program control-
ling Th2 cell responses.
RESULTS
Conditional Deletion of Klf4 Alters Development of
IRF4-Expressing pre-cDCs
Klf4 expression was transiently upregulated at the bone
marrow (BM) pre-cDC stage, whereas Irf8 was induced in
common DC progenitors (CDPs) (Liu et al., 2009; Akashi
et al., 2000 ; Onai et al., 2007) (Figure 1A). Klf4 expression
within mature splenic cDC subsets was reduced compared to
Irf8 and Irf4 (Figure 1B). We crossed the Klf4fl/fl allele (Katz
et al., 2002) onto Vav1-icre, Itgax-cre, and Lyz2-cre deleter
strains (Caton et al., 2007; de Boer et al., 2003; Clausen
et al., 1999). Vav1-icre induced general hematopoietic Klf4
deletion as expected, whereas Itgax-cre deleted Klf4 only
within cDCs (Figure S1A). Deletion of Klf4 by Vav1-icre resulted
in loss of Ly6Chi monocyte development (Figures S1B and
S1C), as previously reported (Feinberg et al., 2007). Neither
Lyz2-cre- nor Itgax-cre-mediated deletion of Klf4 impaired
Ly6Chi monocyte development, confirming an early develop-
mental requirement for Klf4 in monocyte differentiation and
validating the use of Itgax-cre mice for a cDC restricted dele-
tion of Klf4 (Figures S1B and S1C). Klf4 deletion by Vav1-icre
reduced the expression of IRF4 on pre-cDC (Figure S1E) and
impaired development of SiglecH pre-cDCs (Figures 1C–1E),
which also had reduced IRF4 expression (Figure S1E). Macro-
phage and DC precursors (MDPs) and CDPs were unaltered in
Klf4fl/fl Vav1-icre mice (Figures 1C–1E, S1I). CD11c is induced
at the pre-cDC stage (Naik, 2010; Liu et al., 2007) and compar-
ison of Klf4fl/fl Itgax-cre and cre-negative progenitors showed
few changes in gene expression in CDPs, but increased differ-
ences in pre-cDCs (Figures S1F–S1I). Deletion of Klf4 by Vav1-
icre or Itgax-cre reduced IRF4 expression in progenitors but still(B) Relative expression determined by microarray analysis of the indicated
genes is shown for splenic CD24+ Sirp-a CD11b (CD24) and CD24 Sirp-a+
CD11b+ (CD11b) DCs.
(C and D) DC progenitors in BM were analyzed from wild-type mice (WT),
Klf4fl/fl (cre-neg) or Klf4fl/fl mice crossed onto Vav1-icre (Harker et al., 2002), or
Irf4fl/fl mice crossed into B6.C-Tg(CMV-cre)1Cgn/J (The Jackson Laboratory)
backgrounds. CDP, MDP, and pre-cDC were gated as described (Liu et al.,
2009) in the Experimental Procedures and analyzed for the indicated markers.
(E) The percent of the progenitors from the indicated genotype analyzed in
(C and D) are shown. The experiment was repeated four times, and two mice
per genotype were analyzed. Error bars ± SD, n = 5, Student’s t test. *p < 0.05;
**p < 0.001.
See also Figure S1.
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allowed the divergence of DC progenitors into two major sub-
sets of IRF8+ and IRF4+ cDCs in BM cultures (Figure S1D).
Klf4 Regulates Development of Specific Subsets of
IRF4-Expressing cDCs in Peripheral Tissues
We next examined various lymphoid and peripheral tissue-
resident DC subsets under conditional deletion of Klf4 (Figures
2 and S2). Consistent with a previous report (Park et al., 2012),
there was approximately 50% reduction in total CD11c+
MHC-II+ cells in spleen (Figures 2D and S2G), mostly compro-
mising Sirp-a+ CD24- cDCs (Figures 2D and S2G). Approxi-
mately a 50% reduction of CD11b+ cDCs occurred across
all lymphoid and peripheral tissues examined (Figures 2 and
S2). In skin draining lymph nodes (sLN), one subset within the
migratory cDCs was completely absent (Figures 2A, 2B, and
S2B). In skin, Langerhans cells (LCs) and at least four other
cDCs subsets can be distinguished on the basis of CD207,
CD103, and CD11b (Henri et al., 2010). The CD103+CD207+
cDC subset represents the Batf3-depedendent cDC lineage,
but three other subsets (CD103CD207+, CD207CD11b+, and
CD103CD11bCD207 cDCs) are independent of Batf3 (Edel-
son et al., 2010; Ginhoux et al., 2009) and have distinct transcrip-
tional identities (Miller et al., 2012; Robbins et al., 2008; Bar-On
and Jung, 2010). Among these migratory cDC subsets, deletion
of Klf4 completely impaired development of CD11b CD24
cDCs, previously called ‘‘double negative’’ (DN) cDCs (Malissen
et al., 2014; Henri et al., 2010) and characterized as CD207
CD11b Sirp-a+ CX3CR1+ (Figures 2B, S2A, and S2B and data
not shown). In the dermis, deletion of Klf4 reduced CD11b+
cDCs and increased CD24+ and CD103+ cDCs (Figure S2D).
In the lung, Klf4-deficiency selectively eliminated a Sirp-a+
CD24+ subset (Figures 2E and S2J and S2K), which comprised
20% of cDCs (Figures S2J and S2K), and reduced Sirp-a+
CD24 cDCs. Further, Mgl-2 expression identified the Klf4-
dependent Sirp-a+ CD24+ cDCs in lung (Figure 2E), but not in
sLN (Figure S2C). In mediastinal lymph nodes, Klf4 deficiency
severely reduced Sirp-a+ cDCs, which expressed PD-L2, but
not Mgl2 (Figures S2L and S2M and data not shown). In the liver,
Klf4 deficiency reduced the frequency of Sirp-a+ CD24 cDCs,
which also expressed Mgl-2 (Figure S2H). In mesenteric lymph
nodes, lamina propria, and thymus, Sirp-a+ cDCs were reduced
and CD24+ CD103+ respectively increased in the absence ofKlf4
(Figures S2E and S2F; Figure 2F and S2I). These results highlight
the requirement for Klf4 on the IRF4-expressing, but not IRF8-
dependent cDCs, and suggest heterogeneous expression of
PD-L2 and Mgl2 across the different peripheral tissues (Figures
2E and S2 and data not shown). Expression amounts of IRF4
and IRF8 were analyzed on Klf4fl/fl cre-negative mice (Figure 2C
and data not shown). Among the different IRF4 expressing cDCs,
the Klf4-dependent DN subset showed the highest expression
level for IRF4 (Figure 2C).
A Cell-Intrinsic Requirement for Klf4 in Development of
CD11b– cDCs in sLNs
Previous studies concluded that dermal CD11bMHC-IIhi cells
were conventional DCs based on hematopoietic origin and
dependence on Flt3L (Henri et al., 2010; Mollah et al., 2014),
although these properties also identify progenitors of other he-
matopoietic lineages (McKenna et al., 2000; Mackarehtschian918 Immunity 42, 916–928, May 19, 2015 ª2015 Elsevier Inc.et al., 1995). Thus, we independently assessed the identity
of the sLN Klf4-dependent cells (Figure 3). Klf4-dependent
CD11b cells had morphology similar to other migratory and
resident cDC subsets (Figures 3A and S3A), were not affected
by Lyz2-cre-mediated Klf4 deletion, and were present in
Csf2rb/ mice (Figures 3B and 3C). In contrast, IRF8-depen-
dent CD103+ cDCs develop in Csf2rb/mice but have reduced
surface CD103 expression (Figure 3C) (Edelson et al., 2011).
Moreover, the Klf4-dependent CD11b cells in sLNs were ab-
sent in Flt3l/ and Irf4/ mice (Figures 3B and 3C), confirming
their identity as IRF4-dependent cDCs. Among migratory cDCs,
IRF4 expression was highest on the Klf4-dependent DCs (Fig-
ure S1W). Klf4 deficiency did not impair the development of
CD24+ cDCs, which were absent in Flt3l/ mice (Figures 3B
and 3C), nor the development of LCs, which were severely
reduced in Il34/ mice (Wang et al., 2012; Greter et al., 2012)
(Figure S3F). Klf4-dependent CD11b cells were most similar
in gene expression to migratory CD11b+ cDCs and more
distantly related to resident CD11b+ cDCs and LCs (Figures 3D
and S3G). In Zbtb46gfp mice, the Klf4-dependent CD11b- cells
expressed GFP at amounts similar to migratory CD11b+ cDCs
and resident cDCs in sLN (Figures 3E and S3H–S3J). These re-
sults suggest that Klf4-dependent CD11b cells are bona fide
dendritic cells.
To test for a non-cell intrinsic action of Klf4,we analyzed single-
and mixed-BM chimeras reconstituted with Klf4fl/flItgax-cre and
Zbtb46gfp BM (Figures 3F and S3B–S3D). A hematopoietic
requirement of Klf4 was confirmed by the selective loss of
migratory CD11b cDCs in sLN (Figure 3F) and the reduction of
splenic CD11b+ cDCs (Figure S3B) in chimeras reconstituted
with Itgax-cre Klf4fl/fl BM. We also excluded an indirect action
of Klf4 deficiency on other hematopoietic lineages in regulating
development of migratory CD11b cDCs, because this subset
was positive for GFP expression in chimeras reconstituted
with a 10:1 mixture of Itgax-cre Klf4fl/fl BM and Zbtb46gfp BM
(Satpathy et al., 2012a) (Figures S3C and S3D). As a control, we
observed that similar ratios of GFP-positive and -negative cells
developed within the CD24+ and CD11b+ migratory DC subsets
(Figure S3D). Collectively, these results argue for a cell-intrinsic
requirement for Klf4 acting on migratory CD11b cDCs.
Klf4-DependentMigratory cDCs Transport Antigen from
Skin to sLNs
cDCs residing in the migratory gate transport the majority of
fluorescein isothiocyanate (FITC) from skin to sLNs and the
Klf4-dependent CD11b migratory cDC subset accounted for
a substantial fraction of total antigen transport (Figures 4A–4C).
Itgax-cre Klf4fl/fl and Vav1-icre Klf4fl/fl mice showed reduced
percentage and absolute numbers of FITC+ cells present in
sLNs after FITC painting (Figures 3A, 3B, and S4A). In control
mice, direct examination of FITC+ cells showed roughly similar
contributions to antigen transport by CD11b+ and Klf4-depen-
dent CD11b cDCs, which together accounted for about 90%
of FITC+ cells (Figures 4B, 4C, and S4B). In the absence ofmigra-
tory CD11b cDCs, the relative contribution to antigen transport
by CD24+ cDCs was increased from 10% to roughly 40% (Fig-
ures 4B, 4C, and S4B). In contrast to Irf4/ mice (Bajan˜a
et al., 2012; Gao et al., 2013), deletion of Klf4 did not affect anti-
gen transport, as Klf4-independent migratory CD11b+ cDCs
AB
CD24
C
D
11
b
52%23% 50%
27% 61%36%67%29%
WT
51%45% 51%
46% 64%32%69%29%
sLN resident DCs
CD24
C
D
11
b
WT Vav1-icre cre-negative
Klf4f/f
Itgax-cre
Vav1-icre cre-negative
Klf4f/f
Itgax-cre
sLN migratory DCs
Spleen
CD24
74% 75% 50% 47%
21% 22% 43% 45%
WT Klf4f/fVav1-icre Klf4f/f cre-negative Klf4f/f Itgax-cre
C
D
E
F
CD24
35% 22%
39%3.7%
29% 5.2%
62%3.6%
3.8% 1.2%
67%28%M
gl
2
CD24
Lung DCs
Klf4f/f cre-negative Klf4f/f Itgax-cre
7.9% 16%
46%30%
Klf4f/f cre-negative Klf4f/f Itgax-cre
CD103
78%
2.0%
8.7%
12%
41%
4.6%
16%
38%
Klf4f/f Itgax-creKlf4f/f cre-negative
Small Intestine DCs 
CD103
C
D
11
b
15%
35%
4.6%
12%
47%5.3%
4.9% 75%
Klf4f/f Itgax-creKlf4f/f cre-negative
IRF4
LN migratory cDCs
Irf4 -/-
C
el
ls
 ( 
#)
LN resident cDCs
3704
rCD11b+
1133
rCD24+
7059
CD11b-
3941
623
CD11b+
Figure 2. A Discrete Subset of Migratory cDCs in
Skin-Draining Lymph Nodes Requires Klf4
(A and B) Two-color histograms for CD11b and CD24
expression are gated on live cells for the resident (A) and
migratory (B) gates shown in (S2A).
(C) Single color histograms for intracellular IRF4 expression
of the indicated subsets gated as in Figures 2A and 2B for
resident and migratory DCs isolated from Klf4fl/fl cre-nega-
tive mice. Dotted line shows Irf4/ control cDCs. Numbers
represent geometrical mean values of IRF4 expression on
the gated subsets.
(D) Splenocytes from mice of the indicated genotypes were
pre-gated as cDCs (MHC-IIhi CD11chi) and analyzed for
CD24 and Sirp-a expression. Numbers indicate the percent
of cells in the gate.
(E and F) Two-color histograms for Sirp-a, CD24, CD11b,
CD103, and Mgl2 as indicated in the plots, are shown for live
cells from lung (E) and liver (F) of mice of the indicated ge-
notype. Cells were pre-gated as CD45+ MHC-IIhi CD11c+
CD64. Numbers indicate percent cells in the gates. All
stainings were repeated in at least three independent ex-
periments using at least two mice per genotype.
See also Figure S2.
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(A) Wright’s stain of sort-purifiedmigratory CD11b cDCs (mCD11b), CD11b+ (mCD11b+), or CD24+ (mCD24+) and resident CD11b+(resCD11b+) cDCs. Images
were collected from two independent experiments, cells from two mice were pooled and at least ten cells were evaluated per subset.
(B and C) Representative two-color histograms for CD11b, CD24 (B), and CD103, Sirp-a (C) for cells pre-gated as migratory CD24+ cDCs as in Figure 2B are
shown for sLN cells harvested frommice of the indicated genotypes. Analysis was performed in at least two independent experiments and at least three mice per
genotype were analyzed.
(D)Microarray analysis of gene expression presented asM-plots for sort-purifiedmCD11b+ cDCs,mCD11b cDCs, CD24+migratory cDCs, and resident CD11b+
cDCs harvested from sLN. Colors indicate higher (red) or lower (blue) expression. Shown at the bottom right is the number of genes differing between paired
samples by more than 2-fold.
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subset transported substantial antigen from skin to sLNs, in
both Itgax-cre Klf4fl/fl and Vav1-icre Klf4fl/fl mice (Figures 4B,
4C, and S4B).
Deletion of Klf4 in cDCs Selectively Impairs Th2 Cell
Responses to Pathogens
IRF4-expressing DCs produce IL-23 that drives ILC3 and Th17
cell activation and protect against Citrobacter rodentium and
Aspergillus fumigatus infection (Schlitzer et al., 2013; Satpathy
et al., 2013; Persson et al., 2013). We tested the role of Klf4-
dependent cDCs in IL-23 production and Th17 cell response
by infecting Itgax-cre Klf4fl/fl mice with C. rodentium. We
confirmed that susceptible to C. rodentium infection was
increased in mice where Notch2 was deleted by Itgax-cre
(cNotch2/). These mice lost 10%–15% of their body weight
and succumbed to infection around day 12 (Figures 5A and
5B). In contrast, Itgax-cre Klf4fl/fl mice did not lose weight and
survived infection similar to wild-typeKlf4fl/fl cre-negative control
mice, suggesting normal in vivo activation of ILC3 and Th17 cell
responses. While cNotch2/ mice have severely reduced
splenic ESAM+ cDCs, Klf4 deficiency did not compromise devel-
opment of this subset (Figures S5A–S5C).
Protection against the helminth pathogen Schistosoma
mansoni requires a Th2 cell response (Brunet et al., 1997; Fallon
et al., 2000; Herbert et al., 2004). We infected Klf4fl/fl Itgax-cre
and Il4/ mice with S. mansoni (Figure 5C). Il4/ mice
succumbed to infection after 50 days with an overall mortality
of approximately 75% at 60 days after infection (Figure 5C), as
expected (Brunet et al., 1997; Fallon et al., 2000; Pearce et al.,
1996). Klf4fl/fl Itgax-cre mice succumbed to infection with a
similar rate and kinetic as Il4/ mice, while wild-type control
mice survive beyond 100 days after challenge (Figure 5C).
Because Itgax-cre can induce deletion in cells other than DCs,
including T cells (Figure S1A) (Abram et al., 2014), we tested Th2
and Th17 cell polarization after Klf4 deletion. Deletion of Klf4 by
either Vav1-icre or Itgax-cre did not decrease IL-17, IL-4, and
IL-10 production in Th17 or Th2 cells compared to cre-negative
controls (Figures 5D and 5E), but Batf/Batf3/ T cells were
strongly impaired in all of these cytokines, as expected (Tussi-
wand et al., 2012). Further, deletion of Klf4 by either Vav1-icre
or Itgax-cre also did not reduce intracellular expression of
GATA3 (Figures 5D and 5E). Thus, deletion of Klf4 in T cells
by Vav-icre leaves Th2 cell polarization intact, suggesting that
susceptibility to S. mansoni infection occurred through a mech-
anism other than a T cell intrinsic action.
We also immunized mice with S. mansoni egg antigen (SEA)
(Sabin et al., 1996; Everts et al., 2012; Kane et al., 2008; Pearce
et al., 1991). IL-4 and IL-5 were both produced by T cells har-
vested from sLNs 7 days after SEA immunization of wild-type
cre-negative control mice, but this was substantially and selec-
tively reduced in Klf4fl/fl Itgax-cre mice (Figures S5D–S5G).
Moreover, switching of germinal center B cells from surface
immunoglobulin M (IgM) to IgG1 after SEA-immunization was(E) Shown are single-color histograms for Zbtb46gfp expression for B cells, mCD1
Numbers are the percent of live cells within the indicated gate.
(F) Chimeras were generated by reconstitution of lethally irradiated C57BL/6 mice
Shown are two-color histograms as in (B) for cells pre-gated as migratory cDCs
group were analyzed. See also Figure S3.reduced in Klf4fl/fl Itgax-cre mice relative to cre-negative control
mice (Figures S7H and S7I).
To test whether Klf4 deletion within cDCs impaired the func-
tion of the IRF8- and Batf3-dependent cDCs, we examined
infections by T. gondii and herpes simplex virus (HSV) (Mashaye-
khi et al., 2011; Tussiwand et al., 2012). Control mice cre-nega-
tive Klf4fl/fl and Itgax-cre Klf4fl/fl mice were similarly resistant to
T. gondii infection, while Batf3/ mice were as expected highly
susceptible (Figures S5J and S5K). Second, Itgax-cre Klf4fl/fl
mice, but not Batf3/ mice, generated a robust Th1 cell
response specific for the Gb2 peptide of herpes simplex virus
(HSV) 7 days after infection (Figures S5L and S5M). Also,
cross-presentation of cell-associated antigens was preserved
in Itgax-cre Klf4fl/fl mice (Figure S5N) suggesting that IRF8-
expressing DC were phenotypically and functionally fully pre-
served in Itgax-cre Klf4fl/fl mice.
We also excluded that klf4 deletion resulted in a general prim-
ing defect in the remaining IRF4-dependent cDCs by performing
several DC-T cell cultures, where we did not observe any differ-
ence using either BM derived or isolated DCs from control mice
cre-negative, Itgax-cre or Vav1-icre Klf4fl/fl mice (Figure S5O).
Further, Klf4-dependent DCs did not show superior in vitro prim-
ing ability, but only increased expression of the co-stimulatory
molecules CD80 and CD86 after SEA (data not shown).
Collectively, because deletion of Klf4 in Itgax-cre Klf4fl/fl mice
did not compromise the development of other myeloid subsets
other than cDCs and these mice had normal Th17, Th1, and
CTLcell response toseveral infectionsandantigens,Klf4appears
to be selectively required on DCs for inducing Th2 immunity.
Deletion of Klf4 in cDCs Prevents House Dust
Mite-Induced Allergic Inflammation
Development of asthma is associated with a Th2 cell type
of immunity characterized by the accumulation of eosinophils
(Robinson, 2000; Robinson et al., 1992). In mice, intra-nasal
challenge with extracts of house dust mite (HDM) causes acute
allergic peribronchial Th2 cell inflammation mediated by
CD11b+ cDCS (Hammad et al., 2009; Plantinga et al., 2013;
Williams et al., 2013). Because pulmonarymacrophages express
CD11c, we used Klf4fl/fl Lyz2-cre mice as a control for potential
requirements for Klf4 in pulmonary macrophages. Klf4fl/fl Itgax-
cre mice showed a dramatic reduction in pulmonary accumula-
tion of eosinophils compared to both cre-negative Klf4fl/fl control
mice and Klf4fl/fl Lyz2-cre mice, which had robust eosinophilia
(Figures 6A and 6B). Control cre-negative and Klf4fl/fl Lyz2-cre
mice, but not Klf4fl/fl Itgax-cre mice, had typical asthmatic
features with peribronchial inflammation with substantial leuko-
cyte infiltrations (Figure 6C).
DISCUSSION
Klf4 regulates DCs development beginning in the pre-cDC,
where it impacts the IRF4-expressing branch of cDCs. Deletion1b+, or mCD11b cDCs from sLN of Zbtb46+/gfp mice (Satpathy et al., 2012a).
(WT) using BM from Klf4fl/fl cre-negative or Klf4fl/fl Itgax-cre mice as indicated.
as in Figure S2A. Experiment was performed twice and at least four mice per
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Figure 4. Klf4-Dependent CD11b– cDCs
Account for Substantial Antigen Transport
from Skin to Lymph Nodes
(A) Shown is the contribution to total FITC+ cells by
migratory (open bars) and resident (closed bars)
cDCs in skin draining lymph nodes (sLN) 16 hr after
FITC painting, as a percentage of total FITC+
sLN cells. Error bars ± SD, n = 6, Student’s t test.
***p < 0.001.
(B) Shown is contribution to total FITC+ cells by
each migratory DC subset as a percentage of total
FITC+ sLN cells in mice of the indicated genotypes
16 hr after FITC painting. Error bars ± SD, n = 6,
Student’s t test. ***p < 0.001.
(C) FITC transport by individual migratory cDC
subsets is show as single color histogram from
mice of the indicated genotypes and gates (left
panels). N.P., not present. Numbers indicate the
percent of cells in the indicated gates. The exper-
iment was performed three times, and two mice
per group were used.
See also Figure S4.
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Figure 5. Conditional Deletion of Klf4 in DCs Selectively Impairs Th2 Cell Responses to S. mansoni
(A and B) Survival (A) and weight loss (B) of mice after oral inoculation of C. rodentium (23 109 colony-forming units). Mice used were Klf4fl/fl (n = 20) or Notch2fl/fl
(n = 5) (Satpathy et al., 2013) crossed to Itgax-cre (n = 10) (Caton et al., 2007) (Notch2c/) or Klf4fl/fl cre-negative (cre-neg) (n = 10) as indicated. Experiment was
repeated two times.
(C) Survival of mice after skin inoculation with 100 Schistosoma mansoni cercariae. Mice used were Klf4fl/fl crossed to Itgax-cre (n = 7) or a cre-negative
background, (n = 11), or were Il4/ (Kopf et al., 1993) (n = 7) experiment was repeated three times.
(D) Shown are histograms for intracellular GATA3 and IL-4 staining for CD4+ T cells isolated from mice of the indicated genotypes purified by MACS beads and
passed twice in vitro with anti-CD3 and anti-CD28 under Th2-inducing (solid lines) or Th1-inducing conditions (dotted and shaded) as described (Schraml et al.,
2009). Mice used were Klf4fl/fl crossed to Itgax-cre, Vav1-icre, cre-negative, or Batf/Batf3/ double-deficient mice (Tussiwand et al., 2012). Numbers are the
percent of cells in the indicated gates.
(E) MACs purified T cells frommice of the indicated genotypes as in (D) were polarized under Th1-, Th17-, or Th2-inducing conditions as described (Schraml et al.,
2009). Shown are the percent of T cells positive for intracellular expression of the indicated cytokine or factor for each genotype as a percent of the maximum
expression obtained for cre-negative control T cell samples. Twomice per genotypewere used per experiment and the experiment was repeated four times. Error
bars ± SD, n = 8, Student’s t test.
See also Figure S5.
Immunity 42, 916–928, May 19, 2015 ª2015 Elsevier Inc. 923
010
20
30
B
A
L 
eo
si
no
ph
ils
 (%
)
PBS HDM
1
2
3
PBS HDM
To
ta
l e
os
in
op
hi
ls
 
B
A
L 
( x
10
5 
)
0
A
B
C
CD11c
Si
gl
ec
-F
94%1%
2.1%
40%20%
27%
86%1%
5.7%
79%5%
7.4%
82%0.9%
6.9%
29%26%
33%
PBS 
challenged
HDM 
challenged
PBS challenged HDM challenged 
Klf4f/fLyz2-cre Klf4f/f Itgax-creKlf4f/f cre-negative
Klf4f/fLyz2-cre Klf4f/f Itgax-creKlf4f/f cre-negative
Klf4f/fLyz2-cre 
Klf4f/f Itgax-cre
Klf4f/f cre-negative
Figure 6. Conditional Deletion of Klf4 in DCs Prevents Development
of HDM-Induced Allergic Inflammation
(A) HDM sensitized mice of the indicated genotypes were challenged intra-
nasally with PBS or HDM extract. After 3 days, bronchial alveolar lavage (BAL)
was analyzed for eosinophils by FACS. Shown are eosinophils as a percentage
(left panel) or total numbers recruited into BAL (right panel) and pre-gated as
CD45+ live cells. Mice used were Klf4fl/fl crossed to Itgax-cre (n = 8) or Lyz2-cre
(n = 8) or a cre-negative background (n = 8) 3 mice per genotype used
per experiment. Experiment was repeated three times. Error bars, ± SD, n = 8,
Student’s t test. ***p < 0.001.
924 Immunity 42, 916–928, May 19, 2015 ª2015 Elsevier Inc.of Klf4 by Vav1-icre altered the expression of relatively few
genes, but among these, IRF4 was severely downregulated as
measured by microarray expression and intracellular staining.
Reduction of IRF8 and induction of IRF4 occurs at the SiglecH
pre-cDCs stage, a stage that was severely reduced in Vav1-icre
Klf4fl/fl mice. However, IRF4 expression was not altered in
mature cDCs or in Flt3l generated BM-derived cDCs implying a
developmental rather than an absolute requirement for Klf4 in
the induction of IRF4 expression.
In mature cDCs, Klf4 deletion selectively compromised the
development of particular subsets of IRF4-expressing cDCs.
The subset most clearly dependent on Klf4 was the previously
described migratory subset of CD11bCD24 (DN) cDCs in
sLN. This subset had the highest expression of IRF4 among
migratory cDCs. However, it is still unclear whether impaired
Klf4-dependent cDCs development is caused by reduced
IRF4-expression at a progenitor stage or due to some other
action of Klf4.
The DN migratory cDCs identified here as being Klf4 depen-
dent have been described recently to acquire fluorescently
labeled antigen from non-viableNippostrongylus larvae and sug-
gested to be involved in Th2 cell responses based on in vitro
analysis (Ochiai et al., 2014; Connor et al., 2014). Our results
would support those conclusions by drawing a correlation be-
tween the loss of the DN cDC subset and reduced in vivo Th2
cell responses in Klf4-deficient mice. We also observed a higher
co-stimulatory potential of the Klf4-dependent DN migratory
cDCs relative to other cDC subsets after SEA stimulation. None-
theless, despite the genetic requirement for Klf4 for DN cDC
development, it is still possible that Klf4 controls Th2 responses
by actions in other cDC subsets that are not seemingly affected
by the deletion. Excluding such possibilities awaits the develop-
ment of deleter strains with higher DC-subset specificity.
IRF4-expressing cDCs were recently shown to control Th2
cell responses induced in skin and lungs (Schlitzer et al.,
2013; Gao et al., 2013; Kumamoto et al., 2013; Zhou et al.,
2014; Williams et al., 2013), although no mechanism for this ac-
tion was determined. Irf4/ cDCs fail to migrate to sLN (Bajan˜a
et al., 2012) and show reduced expression of co-stimulatory
molecules (Vander Lugt et al., 2014), which could explain
reduced T cell priming, at least in skin. Klf4 deletion selectively
impaired Th2 cell responses without preventing migration of the
remaining cDCs.
IRF4-expressing cDCs also control Th17 cell responses in
lungs and intestine (Schlitzer et al., 2013; Lewis et al., 2011;
Satpathy et al., 2013). We find that in the lung, Klf4 deletion
selectively eliminated an IRF4-dependent cDC subset charac-
terized by the expression of Sirp-a+ CD24+ Mgl-2+. Conceiv-
ably, Klf4-dependent Sirp-a+ CD24+ lung cDCs might mediate
Th2 cell responses to HDM, while Klf4-independent Sirp-a+
CD24 cDCs mediate Th17 cell immunity to fungal infections.(B) Mice of the indicated genotypes were challenged as in (A) and BAL
analyzed by flow cytometry after 3 days. Shown are two-color histograms
pre-gated on CD45+ BAL cells. Numbers indicate percentage of cells in the
indicate gates for eosinophils (SiglecF+ CD11c) or pulmonary macrophages
(SiglecF+ CD11c+), respectively.
(C) Shown are hematoxylin and eosin stained sections of lungs from mice
described in (A) as indicated. Scale bars represent 200 mm.
Alternately, Klf4 might act on both IRF4-expressing cDC sub-
sets but selectively influence Th2, but not Th17, cell priming.
Similarly, in the small intestine, Th17 cell immunity against
C. rodentium infection has been attributed to the action of a
Notch2-dependent subset of IRF4-expressing cDCs (Lewis
et al., 2011; Satpathy et al., 2013). Klf4 deletion did not in-
crease susceptibility to C. rodentium infection and did not
impair development of the splenic Notch2-dependent ESAM-
expressing cDC subset. Thus, in the intestine as well, distinct
transcriptional programs regulated by either Notch2 or Klf4
appear to control different types of immunity mediated by the
IRF4-expressing cDCs.
Our results show a genetic requirement for Klf4 in cDCs for
Th2 cell immunity; however, they do not reveal the cellular
mechanism mediating Th2 cell responses. The in vivo trigger
for Th2 cell development has been elusive, with many mecha-
nisms proposed over time. Conceivably, a particular cDC
subset could directly induce Th2 development, for example
by production of a cytokine or expressing a specific surface re-
ceptor. Alternately, the cDC subset could recruit an accessory
cell that favors and creates the necessary microenvironment
for Th2 cell priming. Indeed, recent evidence suggests the
involvement of innate lymphoid cells type 2 (ILC2s) in the
lung (Halim et al., 2014; Licona-Limo´n et al., 2013; Halim
et al., 2012) and of eosinophils in the intestine (Chu et al.,
2014). It will be important to determine whether Klf4-dependent
cDCs utilize these cells, because such a mechanism would not
be re-capitulated by in vitro studies using isolated co-cultures
of cDCs and T cells.
EXPERIMENTAL PROCEDURES
Mice
All animals were bred andmaintained in a specific pathogen-free animal facility
according to institutional guidelines and with protocols approved by the
Animal Studies Committee at Washington University in St. Louis. Mice of the
following genotypes were purchased from Jackson Laboratories: wild-type
mice C57BL6 (C57BL/6J), Itgax-cre (B6.Cg-Tg(Itgax-cre)1-1Reiz/J) (Caton et al.,
2007), Vav1-icre (B6.Cg-Tg(Vav1-cre)A2Kio/J) (Harker et al., 2002), Lyz2-cre
(B6.129P2-Lyz2tm1(cre)Ifo/J) (Clausen et al., 1999), and Cx3cr1gfp (B6.129P-
Cx3cr1tm1Litt/J) (Jung et al., 2000). Irf4/ were generated in our facility by
backcrossing Irf4fl/fl mice (B6.129S1-Irf4tm1Rdf/J) to the cytomegalovirus
(CMV) promoter expressing CMV-cre mice (B6.C-Tg(CMV-cre)1Cgn/J), both
purchased from Jackson Laboratories. Csf2rb/ (B6.129S1-Csf2rbtm1Cgb/J)
and Flt3l/ (C57BL/6-flt3Ltm1Imx) were obtained from Taconic. Irf8/ mice
were obtained from the European Mutant Mouse Archive and maintained on
the C57BL/6 background. Notch2fl/flItgax-cre were generated and maintained
as described (Satpathy et al., 2013). Klf4fl/fl mice were obtained from MMRC
(MMRRC line 29877) and backcrossed to Itgax-cre, Vav1-icre, Lyz2-cre.
Zbtb46gfp were generated as previously described (Satpathy et al., 2012a).
Batf3/ were generated as previously described (Hildner et al., 2008).
Il4/(B6.129P2-Il4tm1Cgn/J) (Kopf et al., 1993) mice were obtained from EJ
Pearce (Pearce et al., 1996). For BM chimera experiments, the CD45.1+
B6.SJL (B6.SJL-PtprcaPepcb/BoyJ) mice were purchased from Jackson
Laboratories. Unless otherwise indicated, experiments used sex- and age-
matched littermates between 6 and 12 weeks of age.
Infection Models
All animal model studies described were done in accordance with institutional
guidelines and with protocols approved by the Animal Studies Committee at
Washington University in St. Louis.
ForCitrobacter rodentium infection Mice were orally inoculated with 23 109
colony-forming units of C. rodentium, strain DBS100 (American Type CultureCollection) as described (Lee et al., 2012). Survival and weight loss were
monitored over 30 days. Mice used for C. rodentium experiments weighed
less than 22 g.
For Toxoplasma gondii infection, the type II Prugniaud strain of T. gondii
expressing a firefly luciferase and GFP transgene (PRU-FLuc-GFP) (provided
by J. Boothroyd, Stanford University) was used in all tachyzoite experiments.
The parasites were grown in human foreskin fibroblasts cultures as described
(Mashayekhi et al., 2011). For infection, freshly egressed parasites were
filtered, counted, and 100 tachyzoites per mouse were injected intraperitone-
ally. Survival of mice was monitored over 30 days; parasite burden was
measured every 2 days as described below.
Snails infected with S. mansoni (strain NMRI, NR-21962) were provided by
the Schistosome Research Reagent Resource Center for distribution by BEI
Resources, NIAID NIH. Mice were each infected by percutaneous exposure
to 100 cercariae. S. mansoni Egg Antigen (SEA) was made from parasite
eggs isolated from the livers of infected mice, as previously described
(MacDonald et al., 2001). Mice were each immunized with 50 mg of SEA
subcutaneously (s.c.) into a rear footpad. For Herpes simplex virus 1 (HSV-1)
infection mice were infected with the KOS strain s.c. with 1.5 3 105 plaque-
forming units (pfu) per mouse in the footpad.
In Vitro T Cell Re-stimulation after SEA and HSV Infection
One week after HSV infection, spleens and popliteal lymph nodes (LN) were
collected and re-stimulated with the HSV peptide HSV-gB2 (498-505) (Anas-
pec). Briefly, 2 3 106 splenocytes or LN cells were re-stimulated for 5ch in
the presence of brefeldin A at 1 mgcml1 and analyzed by FACS for intracel-
lular IFN-g and TNF-a production as described later.
Similarly, 1 week after SEA injection, 3 3 105 cells harvested from
popliteal lymph nodes were collected and restimulated under different
conditions: SEA (20 mg/ml), plate-bound anti-CD3, PMA and Ionomycin
(50ng/ml and 1 mg/ml), or media alone. For detection of IL-4, 2.5 mg /ml of
anti-IL-4R antibody (M1) was added to the culture. Supernatants were
collected after 72 hr and analyzed with the BD CBA mouse Th1/Th2
Kit (BD Biosciences), and data were analyzed with FCAP Array software
(Soft Flow).
HDM-Induced Asthma
HDM (Dermatophagoidespteronyssinus extracts, Greer Laboratories) was dis-
solved in PBS. To induce allergic airway inflammation, we sensitized mice i.n.
10 mg HDM subsequently challenged with 50 mg HDM i.n. on days 7 and
collected lungs, BAL, and mediastinal LNs 3 days after challenge.
Statistical Analysis
Differences between groups in survival were analyzed by the log rank test.
Analysis of all other data was done with an unpaired, two-tailed Student’s
t test with a 95% confidence interval (Prism; GraphPad Software). p values
less than 0.05 were considered significant. *0.01 < p < 0.05; **0.001 < p <
0.01; ***p < 0.001; ****p < 0.0001.
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